
Investing.com-- The Dow closed higher Friday to clinch its fourth-weekly win as the broadening out of the rally amid mostly stronger quarterly results continued to support stocks just as signs of sticker inflation muddies the outlook for sooner rate cuts.
At 16:00 ET (21:00 GMT), the Dow Jones Industrial Average rose 125 points, or 0.3%, the S&P 500 gained 0.1%, and the NASDAQ Composite closed just below the flatline, down 0.03%. The main Wall Street indexes posted weekly gains of between 1% and 2%.
The University of Michigan Survey of Consumers sentiment index fell to reading of 67.4 for May, down from 77.2 in April as one-year inflation climbed to 3.5%, up from 0.4% a month ago.
The fresh signs of consumer jitters about rising price pressure come just as Fed speakers continue to signal a wait and see approach about whether to cut rates.
Minneapolis Fed Pres. Kashkari expressed caution Friday about whether the current level of interest rates are restrictive enough, saying that he couldn't rule out the possibility of a rate hike.
As the curtain closes on the earnings season, investors continued to cheer mostly better-than-expected quarterly results.
Sweetgreen Inc (NYSE:SG) was among the highlights on the earnings stage after the salad chain upgraded its full-year guidance and reported quarterly results that beat on both the top and bottom lines, sending its shares 34% higher. The positive results come as other food chains have struggled to sustain momentum amid a weakening consumer.
In chips, Taiwan Semiconductor Manufacturing (NYSE:TSM) led the charge, up 4.5%, as its 60% jump in April revenue from a year ago underscored the strength in demand for artificial-intelligence-related hardware, helping other chipmakers add to gains.
But it wasn't all positive as cloud services firm Akamai Technologies (NASDAQ:AKAM) reported disappointing guidance for the current quarter and for 2024, stoking a negative reaction from Wall Street as its shares fell 11%.
Videogame software developer Unity Software (NYSE:U), meanwhile, fell more than 10% to a 52-week low after its quarterly earnings per share missed estimates as
Well over 80% of the S&P 500 have reported first quarter results, and companies are on track to have increased earnings by 7.8%, up from an expectation of 5.1% growth in April, according to LSEG IBES.
Novavax (NASDAQ:NVAX) stock more than doubled stock after the biotech company signed a deal with French drugmaker Sanofi (NASDAQ:SNY) to develop its Covid vaccine starting next year.
Moderna (NASDAQ:MRNA) stock fell 4% after the drugmaker announced that the Food and Drug Administration has delayed the approval of its vaccine for respiratory syncytial virus to the end of May due to "administrative constraints" at the agency.
(Peter Nurse, Ambar Warrick contributed to this article.)
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.